'Marked increase' in peptide users utilising needle exchange facilities
Experts and advocates fear at-risk drug users could be left without safe injecting equipment and resort to syringe-sharing.
Concerns are growing among needle exchange facilities about a surge in peptide use, which threatens to deplete the supply of needles for at-risk drug users. The Queensland Injectors Health Network (QuIHN) reported a marked increase in peptide users visiting their facilities since last year. Geoff Davey, the chief executive of QuIHN, stated that the issue is not just local but a nationwide trend.
Peptides, short chains of amino acids forming proteins, are used for various reasons, including weight loss and body enhancement. However, many unregulated peptides, not approved for human use, are sold online, posing health risks. These unregulated peptides, often marketed for drastic body transformations, are causing worry among health experts.
While some peptide users are seeking health advice, there are concerns about those who aren't. The QuIHN and other organizations are struggling to meet the rising demand for injecting equipment, potentially leading to layoffs to cut costs. Health authorities emphasize the importance of connecting at-risk users with harm reduction organizations that can provide credible advice and safe injecting equipment.
The current program, which has successfully prevented HIV infections and saved millions, is threatened by the increased demand for resources.
Written by urgent.news from ABC News AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
